Sustainability & Climate

Israeli tech firm Terrific Innovation partners with BrandCloud to bring its owned-channel video commerce platform to Japan's massive, untapped market.

A leading flavor firm predicts our next culinary obsession. Discover why dark sweet cherry, from nostalgic roots to social media fame, is set to dominate 2026.

Leatt Corp signals confidence by extending its share buyback, but does strong financial performance justify the move amid recent stock market slides?

As gold, silver, and platinum hit historic highs, Deutsche Bank is issuing new securities for its physically-backed Xtrackers products to meet demand.

The all-new 2026 Palisade Hybrid earns a top industry honor, blending potent performance with family-focused luxury and cutting-edge tech.

A music legend's donation fuels a new model for equitable recovery, helping Black communities in LA rebuild not just homes, but generational wealth.

Zefr's patent for a human-AI system gives advertisers unprecedented control by understanding content context, not just keywords, on social platforms.

A revolutionary, non-toxic wood treatment is entering the market, promising to make homes safer from wildfires and disrupt a billion-dollar industry.

A major foundation is investing $75.8M to build a responsible public architecture for AI, funding projects that prioritize human rights and global equity.

With a $60M backing from a mystery investor, U Power plans to bring its AI-driven battery swapping tech to Southern Europe. Can it succeed?

Falco Resources restructures key debt and names a new board chair, gaining critical runway to advance its massive Horne 5 gold project in Quebec.

Southchip posts its 11th straight quarter of revenue growth, but falling margins and a huge R&D spend reveal a bold, high-risk expansion strategy.

Zephyrus Innovations just got FDA clearance for VaporShield, a device protecting nurses from drug exposure. It’s a story of safety, market disruption, and efficiency.

Vantage's recent triple award win for trust, tech, and social good is more than a trophy. It reveals the new anatomy of a broker's identity.

A breakthrough clinical trial and a savvy financial move could net Fractyl Health $18M to advance its novel obesity treatment beyond the GLP-1 boom.

Biotech Immunome plans a massive stock offering. A deep dive into the high-stakes bet on its cancer pipeline and what it means for investors.

A $1.2M investment isn't just charity; it's a strategic push for 'whole-person health' aimed at fixing the Pacific Northwest's deepest care gaps.

Ford hits the brakes on its aggressive EV plan, pivoting to profitable hybrids and a bold new venture in battery energy storage. What does this mean?

Kodiak Sciences is raising crucial capital with a stock offering, diluting investors but fueling its late-stage retinal drugs. Is this a necessary lifeline or a red flag?

Verastem Oncology taps industry heavyweights for its leadership, signaling a bold new strategy to accelerate its cancer pipeline and grow its market share.